
Founded in 2015, Orchard Therapeutics aspires to end the devastation caused by genetic and other severe diseases through the curative potential of HSC gene therapy. With its global and U.S. headquarters in London and Boston, respectively, the company offers a diverse and dynamic work environment and is always looking to expand its team with talented individuals who are passionate about making a difference for patients and their families.
The Virtual Speed Networking event will give attendees an opportunity to gain industry knowledge and network with several mentors from different functions across the organisation, as well as provide an opportunity to learn more about Orchard and the biopharmaceutical industry. Attendees will also be given the opportunity to establish and form meaningful professional relationships with the mentors for potential future career advice and coaching.
OUR GUESTS
Tina Khanna
Snr Manager, Clinical Operations
Tina recently joined Orchard Therapeutics from Shionogi Europe. Alongside Study Management she also has Line Management and mentoring experience. She has enjoyed this aspect of her role as she found guiding and training junior members of the team very rewarding.

Jennifer Turnbull
Manager, Pharmacovigilance, Training, Oversight, Compliance
Jennifer joined Orchard Therapeutics earlier this year. She previously worked at GSK for over 8 years where she was in PV operations which involved vendor management, on time reporting QC of SAE reports and working across multifunctional teams in the clinical space.

Claire Newton
Executive Director,
Program Mngmt & Leadership
Claire joined Orchard as a Senior Director, Program Leader at the beginning of 2020. She leads Program Strategy Teams to develop integrated cross functional development strategies for Orchard’s assets. Before Orchard, she spent 10 years at Amgen working on marketed and pre-registrational product development and business transformational initiatives.

Meenakshi Chidambaram
Manager, MasterControl System
Corporate QA
Meena joined Orchard around a year ago. Her career spans 25 years across Academia, NHS and Pharma Industry/Biotech. She has extensive scientific expertise in mammalian cell-culture/bioreactors and good working knowledge of Quality Management Systems (Good Manufacturing Practice & Good Laboratory Practice).

Alex Bell
Associate Study Manager
Alex has been with Orchard Therapeutics since Autumn 2019. Previously Alex had four years’ experience within clinical research. He has gained his professional experience working for a contract research organisation, that specialises in early phase clinical trials within infectious diseases. He has gained experience in various roles, mainly focusing on clinical operations.
